Literature DB >> 16362612

Pharmacokinetics of flunixin after intravenous administration in healthy and endotoxaemic rabbits.

M Elmas1, E Yazar, K Uney, A Karabacak.   

Abstract

The pharmacokinetics of flunixin were determined after intravenous bolus injection at a single dose (2.2 mg/kg) in healthy rabbits and diseased rabbits with Escherichia coli lipopolysaccharide-induced septic shock. Six adult New Zealand White rabbits were used. Concentrations of drug in plasma were determined by HPLC. Pharmacokinetics were best described by a two-compartment open model. In healthy rabbits, there was a high plasma clearance (0.62 L/(h kg)), and a relatively short elimination half-life (1.19 h). In endotoxaemic rabbits, total plasma clearance (0.43 L/(h kg)) was significantly lower (p<0.05), and elimination half-life (1.90 h) and AUC(0-infinity) (5.29 (microg h)/ml) were significantly higher (p<0.05) than in healthy animals. The changes of pharmacokinetics of flunixin in rabbits with septic shock could be of clinical significance, and may require monitoring of plasma flunixin levels in endotoxaemic status.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16362612     DOI: 10.1007/s11259-005-3227-7

Source DB:  PubMed          Journal:  Vet Res Commun        ISSN: 0165-7380            Impact factor:   2.459


  36 in total

1.  The pharmacokinetics of oxytetracycline following intravenous administration in healthy and diseased pigs.

Authors:  A Pijpers; E J Schoevers; H van Gogh; L A van Leengoed; I J Visser; A S van Miert; J H Verheijden
Journal:  J Vet Pharmacol Ther       Date:  1990-09       Impact factor: 1.786

2.  Pharmacokinetics, metabolism and urinary detection time of flunixin after intravenous administration in camels.

Authors:  I A Wasfi; N S Boni; A Abdel Hadi; M Elghazali; O Zorob; N A Alkatheeri; I M Barezaiq
Journal:  J Vet Pharmacol Ther       Date:  1998-06       Impact factor: 1.786

3.  Possible active transport mechanism in pharmacokinetics of flunixin-meglumin in rabbits.

Authors:  Y Miyazaki; Y Horii; N Ikenaga; M Shimoda; E Kokue
Journal:  J Vet Med Sci       Date:  2001-08       Impact factor: 1.267

Review 4.  Hepatic and extrahepatic pathobiology of bacterial lipopolysaccharides.

Authors:  J A Hewett; R A Roth
Journal:  Pharmacol Rev       Date:  1993-12       Impact factor: 25.468

5.  Application of Akaike's information criterion (AIC) in the evaluation of linear pharmacokinetic equations.

Authors:  K Yamaoka; T Nakagawa; T Uno
Journal:  J Pharmacokinet Biopharm       Date:  1978-04

6.  Influence of induced disease states on the disposition kinetics of imidocarb in goats.

Authors:  A Salam Abdullah; J D Baggot
Journal:  J Vet Pharmacol Ther       Date:  1986-06       Impact factor: 1.786

Review 7.  Nonsteroidal anti-inflammatory drugs.

Authors:  P Kallings
Journal:  Vet Clin North Am Equine Pract       Date:  1993-12       Impact factor: 1.792

8.  The effect of endotoxin and dexamethasone on enrofloxacin pharmacokinetic parameters in swine.

Authors:  Lynn O Post; Dorothy E Farrell; Carol V Cope; John D Baker; Michael J Myers
Journal:  J Pharmacol Exp Ther       Date:  2003-02       Impact factor: 4.030

9.  Measurement of flunixin in equine inflammatory exudate and plasma by high performance liquid chromatography.

Authors:  A J Higgins; P Lees; S C Sharma; J B Taylor
Journal:  Equine Vet J       Date:  1987-07       Impact factor: 2.888

10.  Determination of pharmacokinetics and pharmacodynamics of flunixin in calves by use of pharmacokinetic/pharmacodynamic modeling.

Authors:  M F Landoni; F M Cunningham; P Lees
Journal:  Am J Vet Res       Date:  1995-06       Impact factor: 1.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.